跳至主要内容
临床试验/EUCTR2022-000319-30-CZ
EUCTR2022-000319-30-CZ进行中(未招募)1 期

Assessment of association between 3rd dose of mRNA vaccine and risk of SARS-CoV-2 infection in kidney transplant recipients, safety and immunogenicity assessment.

Institut Klinické a Experimentální Medicíny0 个研究点目标入组 180 人开始时间: 2022年1月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Kidney transplant recipients followed at Institute for Clinical and Experimental Medicine (IKEM)
  • - vaccinated with 2 doses of BNT162b2
  • - immunosuppressive regimen includes mycophenolic acid or mycophenolate mofetil
  • - COVID naive and/or COVID survivors
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 130
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • - age < 18 years
  • - pregnant women, breastfeeding women
  • - unable/unwilling to give informed consent

研究者

相似试验